Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$40.86 - $62.98 $399,324 - $615,503
9,773 New
9,773 $403,000
Q4 2022

Feb 15, 2023

BUY
$24.4 - $41.3 $556,686 - $942,259
22,815 New
22,815 $831,000
Q4 2021

Feb 17, 2022

SELL
$135.05 - $182.59 $1.35 Million - $1.82 Million
-9,982 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$145.58 - $192.14 $216,914 - $286,288
-1,490 Reduced 12.99%
9,982 $1.45 Million
Q2 2021

Sep 17, 2021

BUY
$134.22 - $202.37 $1.54 Million - $2.32 Million
11,472 New
11,472 $2.25 Million
Q4 2020

Feb 24, 2021

SELL
$126.47 - $163.7 $274,819 - $355,720
-2,173 Closed
0 $0
Q3 2020

Dec 11, 2020

BUY
$87.44 - $125.0 $190,007 - $271,625
2,173 New
2,173 $271,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.